Pictet Asset Management (UK)’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
$3.35M Buy
336,450
+28,400
+9% +$283K ﹤0.01% 919
2021
Q1
$3.51M Sell
308,050
-13,247
-4% -$151K ﹤0.01% 900
2020
Q4
$3.06M Buy
321,297
+8,260
+3% +$78.6K ﹤0.01% 900
2020
Q3
$2.84M Sell
313,037
-19,670
-6% -$178K ﹤0.01% 842
2020
Q2
$4.01M Buy
332,707
+14,478
+5% +$174K 0.01% 741
2020
Q1
$2.93M Buy
318,229
+13,010
+4% +$120K 0.01% 769
2019
Q4
$3.02M Buy
305,219
+9,739
+3% +$96.5K 0.01% 846
2019
Q3
$2.03M Sell
295,480
-1,860
-0.6% -$12.8K ﹤0.01% 844
2019
Q2
$2.73M Buy
297,340
+36,587
+14% +$335K 0.01% 803
2019
Q1
$4.06M Sell
260,753
-10,312
-4% -$161K 0.01% 725
2018
Q4
$4.25K Buy
271,065
+4,400
+2% +$69 0.01% 686
2018
Q3
$5.85M Sell
266,665
-1,100
-0.4% -$24.1K 0.01% 679
2018
Q2
$6.51M Sell
267,765
-51,964
-16% -$1.26M 0.02% 607
2018
Q1
$5.46M Sell
319,729
-6,610
-2% -$113K 0.01% 647
2017
Q4
$6.18M Sell
326,339
-29,012
-8% -$550K 0.02% 614
2017
Q3
$6.25M Sell
355,351
-2,671,134
-88% -$47M 0.02% 587
2017
Q2
$84.3M Buy
3,026,485
+12,397
+0.4% +$345K 0.26% 118
2017
Q1
$96.7M Sell
3,014,088
-30,503
-1% -$979K 0.32% 91
2016
Q4
$110M Buy
3,044,591
+1,302,198
+75% +$47.2M 0.41% 66
2016
Q3
$80.2M Buy
1,742,393
+1,397,920
+406% +$64.3M 0.3% 92
2016
Q2
$17.9M Sell
344,473
-39,104
-10% -$2.03M 0.07% 320
2016
Q1
$21.3M Buy
383,577
+89,933
+31% +$5M 0.09% 247
2015
Q4
$19.3M Buy
293,644
+71,520
+32% +$4.69M 0.08% 288
2015
Q3
$12.5M Buy
222,124
+28,992
+15% +$1.64M 0.06% 356
2015
Q2
$13.3M Sell
193,132
-609,420
-76% -$42.1M 0.05% 368
2015
Q1
$48.5M Buy
802,552
+759,150
+1,749% +$45.9M 0.2% 132
2014
Q4
$2.5M Buy
43,402
+7,300
+20% +$420K 0.01% 715
2014
Q3
$1.94M Sell
36,102
-2,500
-6% -$134K 0.01% 738
2014
Q2
$2.02M Buy
38,602
+6,100
+19% +$320K 0.01% 734
2014
Q1
$1.72M Buy
32,502
+13,300
+69% +$703K 0.01% 752
2013
Q4
$770K Sell
19,202
-2,400
-11% -$96.2K ﹤0.01% 794
2013
Q3
$816K Buy
21,602
+4,300
+25% +$162K ﹤0.01% 786
2013
Q2
$678K Buy
+17,302
New +$678K ﹤0.01% 791